Recombinant human lactoferrin is produced by introducing the gene for lactoferrin into a host cell, such as a bacterial or mammalian cell, which then produces the lactoferrin protein
subcutaneous injection is a research/community practice with weak pharmacologic rationale, since the peptides plasma half-life is only minutes [4]
iScience 20 , 466480 (2019)
All products include manufacturer COAs and/or independent lab testing
In addition, PG-CAT supplementation at a time subsequent to RSV inoculation resulted also in an improvement of RSV-induced airway obstruction measured at day 1 post-infection and AHR measured at a later time point of infection (day 5), but not clinical disease or body weight loss
Furthermore, BPC 157 demonstrated a benecial effect on pulmonary hy- pertension [ 12 , 13 ]